Protecting the Public Health: Examining FDA's Initiatives and Priorities, Hearing Before the U.S. Senate Committee on Health, Education, Labor, and Pensions, One Hundred Thirteenth Congress, Second Session, March 13, 2014 [open pdf - 233KB]
This testimony compilation is from the March 13, 2014 hearing on "Protecting the Public Health" held before the Senate Committee on Health, Education, Labor, and Pensions. From the testimony of Margaret Hamburg: "Mr. Chairman and Members of the Committee, I am Dr. Margaret Hamburg, Commissioner of Food and Drugs at the Food and Drug Administration (FDA or the Agency), which is part of the Department of Health and Human Services (HHS). Thank you for the opportunity to be here today to provide an overview of the important actions and initiatives FDA has been working on over the last year, including implementation of several new laws passed with this Committee's leadership: the FDA Food Safety Modernization Act (FSMA), Public Law 111-353; the Food and Drug Administration Safety and Innovation Act (FDASIA), Public Law 112-144; and the Drug Quality and Security Act (DQSA), Public Law 113-54. I would like to express my gratitude to you and the Members of this Committee for championing passage of these landmark laws, all of which directly impact the public health. Their importance cannot be overstated, and the breadth of their provisions touch and guide so much of what we do every day. I appreciate the opportunity to provide this Committee with an overview of the Agency's implementation of various provisions of these laws." Statements, letters, and materials submitted for the record include those of Margaret Hamburg.
U.S. Senate Committee on Health, Education, Labor, and Pensions: http://www.help.senate.gov/